Hans Olof Glise

Board of Directors, MCI, Medical consultant and Innovation Holding AB

StockholmSE5 active roles

Hans Olof Glise is a SE director with 5 active roles across Swedish companies, including Board of Directors at MCI, Medical consultant and Innovation Holding AB.

Overview

Active roles

directorships & management

Past roles

historical positions

Dissolved companies

in directorship history

Career timeline

2023 – now
External Signatory, Astra Hässle Aktiebolag
2023 – 2023
Board of Directors, CarryGenes Therapeutics AB
2022 – now
Deputy Board Member, Accelerated Innovation mobile health, Europe AB
2022 – now
Deputy Board Member, AI Cognitive Health AB
2022 – 2022
Board of Directors, ISR Immune System Regulation Holding AB (publ)
2022 – 2022
Board of Directors, ISR Vaccine AB
2021 – now
Board of Directors, MCI, Medical consultant and Innovation Holding AB
2020 – 2023
Board of Directors, ISR Oncology AB
2020 – 2022
Board of Directors, ITH Immune Therapy Holdings AB
2020 – 2022
Board of Directors, TLA Targeted Immunotherapies AB
2020 – 2022
Board of Directors, Accelerated Innovation, Europe AB
2020 – 2020
Board of Directors, CarryGenes Oncology AB
2014 – now
Board of Directors, Nanofactory Instruments AB

Personal details

Nationality

Address

Stockholm

Hans Olof Glise

Overview

Career timeline

Personal details

More on Hans Olof Glise

Overview

Career timeline

Personal details

More on Hans Olof Glise